CSI Market
Sign In | Register

Avalo Therapeutics Inc (AVTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access AVTX quarterly Balance Sheets →
The table below presents a historical view of Avalo Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent15.86
Restricted Cash and Cash Equivalents, Current0.04
Short-term Investments, Total82.48
Cash & Short-term Investments97.00
Accounts receivable0.00
Other Receivables, Net, Current0.00
Inventories0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.91
Total Current Assets105.29
Goodwill net10.50
Intangible Assets0.00
Long-term investments0.21
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent DI0.00
Other Assets, Noncurrent0.67
Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization0.46
Total Assets116.46
Liabilities
Accounts Payable, Current AC0.14
Accrued Liabilities, Current2.00
Derivative Liability, Current DE0.00
Notes Payable, Current NO0.00
Other Liabilities, Current10.80
Deferred Revenue DE0.00
Total Current Liabilities12.94
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE18.00
Other liabilities, Noncurrent2.47
Deferred Income Tax Liabilities Net0.43
Total Liabilities33.41
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock531.49
Retained Earnings / Accumulated Deficit-448.52
Other Equity0.07
Common Stockholder's Equity83.05
Total Stockholder's Equity83.05
Liabilities & Stockholder's Equity116.46
4 historic quarters locked

Sign in to unlock the full Avalo Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Avalo Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001534120-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License